Cover Image
Market Research Report
Product code 
1081221

Plasma Derived Therapy Market Size By Product, By Application, Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030

Published: | Global Market Insights Inc. | 108 Pages | Delivery time: 2-3 business days

Price

Back to Top
Plasma Derived Therapy Market Size By Product, By Application, Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030
Published: May 18, 2022
Global Market Insights Inc.
Content info: 108 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The plasma derived therapy market is likely to observe robust growth through 2030 driven by increasing prevalence of rare diseases.

Growing dependence on plasma-based therapies to effectively treat a range of inhibitor deficiencies, bleeding disorders, and primary as well as secondary immunodeficiencies has played a key role in market development. Blood donation organizations, such as NHS Blood and Transplant (NHSBT) and American Red Cross, have accelerated blood donation to derive large volumes of blood plasma for use in the field of medicine.

Recently, in July 2021, the NHSBT launched its first initiative to encourage plasma donation. With this move, the organization addressed the lack of awareness regarding plasma donation in the UK and appealed to 14,500 individuals to start donating plasma. The initiative was designed to reinstate donation and strengthen new plasma donation networks.

Following the COVID-19 outbreak, there was a surge in demand for plasma as part of the treatment of patients infected with the novel coronavirus. In January 2022, Red Cross, a prominent non-profit organization, announced that it was amidst the worst blood shortage in more than a decade in light of rising Omicron cases, which caused a further decline in donor turnout. Consequently, the booming need for plasma in COVID-19 therapy has propelled product demand significantly during the pandemic.

Moreover, key industry players have also been adopting lucrative strategies to obtain a competitive edge in the market, which has been favorable for plasma derived therapy market expansion. For instance, in January 2022, Octapharma, a major protein manufacturer in the pharma space, introduced its human immunoglobulin dubbed cutaquig for subcutaneous administration in the EU market. This novel treatment for secondary immunodeficiency diseases is a ready-to-use, liquid immunoglobulin therapy and targets patients in need of immunoglobulin replacement therapy.

The global plasma derived therapy market has been segmented based on product, application, and region. By product, the industry has been categorized into albumin, coagulation factors, immunoglobulins, and others. Of these, the coagulation factors product segment is estimated to exhibit a CAGR of around 7.4% through the review period. Surging number of hemophilia cases and the increasing global pediatric population suffering from rare illnesses are expected to fuel product demand.

With regards to application, the plasma derived therapy market has been bifurcated into primary immunodeficiency diseases, immune thrombocytopenic purpura (ITP), hemophilia, and others. In 2021, the primary immunodeficiency diseases segment acquired around 25.2% market share. Increasing healthcare expenditure, coupled with growing awareness about treatment for primary immunodeficiency diseases, is likely to bolster segmental adoption.

In terms of region, the Latin America plasma derived therapy market is projected to showcase around 7.2% CAGR over the assessment period. Improving healthcare infrastructure, along with increasing government funding and initiatives that are boosting the adoption of advanced therapies in healthcare facilities across LATAM, is slated to accelerate regional business through the forecast period.

Product Code: 5271

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle east & Africa
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Plasma derived therapy industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 Regional trends

Chapter 3 Plasma Derived Therapy Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing prevalence of rare diseases
      • 3.3.1.2 Growing demand for advanced therapeutic for treatment of genetic disorders
      • 3.3.1.3 Increase in number of plasma collection centers across the globe
      • 3.3.1.4 Rising adoption of immunoglobulins across the nation
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 Stringent regulatory policies
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By application
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2021
  • 3.9 PESTEL analysis

Chapter 4 Plasma Derived Therapy Market, By Product

  • 4.1 Key segment trends
  • 4.2 Coagulation factors
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Immunoglobulins
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Albumin
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Plasma Derived Therapy Market, By Application

  • 5.1 Key segment trends
  • 5.2 Primary immunodeficiency diseases
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Hemophilia
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Idiopathic thrombocytopenic purpura (ITP)
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Plasma derived therapy Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size by country, 2017 - 2030 (USD Million)
    • 6.2.2 Market size by product, 2017 - 2030 (USD Million)
    • 6.2.3 Market size by application, 2017 - 2030 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.2.4.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.2.5.2 Market size by application, 2017 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size by country, 2017 - 2030 (USD Million)
    • 6.3.2 Market size by product, 2017 - 2030 (USD Million)
    • 6.3.3 Market size by application, 2017 - 2030 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.3.4.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.3.5 UK
      • 6.3.5.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.3.5.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.3.6 France
      • 6.3.6.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.3.6.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.3.7 Italy
      • 6.3.7.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.3.7.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.3.8 Spain
      • 6.3.8.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.3.8.2 Market size by application, 2017 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size by country, 2017 - 2030 (USD Million)
    • 6.4.2 Market size by product, 2017 - 2030 (USD Million)
    • 6.4.3 Market size by application, 2017 - 2030 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.4.4.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.4.5 China
      • 6.4.5.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.4.5.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.4.6 India
      • 6.4.6.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.4.6.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.4.7 Australia
      • 6.4.7.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.4.7.2 Market size by application, 2017 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size by country, 2017 - 2030 (USD Million)
    • 6.5.2 Market size by product, 2017 - 2030 (USD Million)
    • 6.5.3 Market size by application, 2017 - 2030 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.5.4.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.5.5 Mexico
      • 6.5.5.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.5.5.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.5.6 Argentina
      • 6.5.6.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.5.6.2 Market size by application, 2017 - 2030 (USD Million)
  • 6.6 Middle East & Africa (MEA)
    • 6.6.1 Market size by country, 2017 - 2030 (USD Million)
    • 6.6.2 Market size by product, 2017 - 2030 (USD Million)
    • 6.6.3 Market size by application, 2017 - 2030 (USD Million)
    • 6.6.4 South Africa
      • 6.6.4.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.6.4.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.6.5 Saudi Arabia
      • 6.6.5.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.6.5.2 Market size by application, 2017 - 2030 (USD Million)
    • 6.6.6 UAE
      • 6.6.6.1 Market size by product, 2017 - 2030 (USD Million)
      • 6.6.6.2 Market size by application, 2017 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Competitive dashboard, 2021
  • 7.2 CSL Behring
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 Takeda Pharmaceutical Company Limited.
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 Biotest AG
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 Octapharma
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 BPL
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 ADMA Biologics
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Grifols, SA
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 Kedrion
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Kamada Pharmaceuticals.
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 SK Plasma.
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis
  • 7.12 Pfizer
    • 7.12.1 Business overview
    • 7.12.2 Financial data
    • 7.12.3 Product landscape
    • 7.12.4 Strategic outlook
    • 7.12.5 SWOT analysis

Data Tables

  • TABLE 1. Global plasma derived therapy market, 2017 - 2021 (USD Million)
  • TABLE 2. Global plasma derived therapy market, 2022 - 2030 (USD Million)
  • TABLE 3. Global plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 4. Global plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 5. Global plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 6. Global plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 7. Global plasma derived therapy market, by region, 2017 - 2021 (USD Million)
  • TABLE 8. Global plasma derived therapy market, by region, 2022 - 2030 (USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Coagulation factors market size, by region, 2017 - 2021 (USD Million)
  • TABLE 11. Coagulation factors market size, by region, 2022 - 2030 (USD Million)
  • TABLE 12. Immunoglobulins market size, by region, 2017 - 2021 (USD Million)
  • TABLE 13. Immunoglobulins market size, by region, 2022 - 2030 (USD Million)
  • TABLE 14. Albumin market size, by region, 2017 - 2021 (USD Million)
  • TABLE 15. Albumin market size, by region, 2022 - 2030 (USD Million)
  • TABLE 16. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 17. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 18. Primary immunodeficiency diseases market size, by region, 2017 - 2021 (USD Million)
  • TABLE 19. Primary immunodeficiency diseases market size, by region, 2022 - 2030 (USD Million)
  • TABLE 20. Hemophilia market size, by region, 2017 - 2021 (USD Million)
  • TABLE 21. Hemophilia market size, by region, 2022 - 2030 (USD Million)
  • TABLE 22. Idiopathic thrombocytopenic purpura (ITP) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 23. Idiopathic thrombocytopenic purpura (ITP) market size, by region, 2022 - 2030 (USD Million)
  • TABLE 24. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 25. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 26. North America market, by country, 2017 - 2021(USD Million)
  • TABLE 27. North America market, by country, 2022 - 2030 (USD Million)
  • TABLE 28. North America plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 29. North America plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 30. North America plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 31. North America plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 32. U.S. plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 33. U.S. plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 34. U.S. plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 35. U.S. plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 36. Canada plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 37. Canada plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 38. Canada plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 39. Canada plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 40. Europe market, by country, 2017 - 2021(USD Million)
  • TABLE 41. Europe market, by country, 2022 - 2030 (USD Million)
  • TABLE 42. Europe plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 43. Europe plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 44. Europe plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 45. Europe plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 46. Germany plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 47. Germany plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 48. Germany plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 49. Germany plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 50. UK plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 51. UK plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 52. UK plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 53. UK plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 54. France plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 55. France plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 56. France plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 57. France plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 58. Italy plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 59. Italy plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 60. Italy plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 61. Italy plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 62. Spain plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 63. Spain plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 64. Spain plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 65. Spain plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 66. Asia Pacific market size, by country, 2017 - 2021(USD Million)
  • TABLE 67. Asia Pacific market size, by country, 2022 - 2030 (USD Million)
  • TABLE 68. Asia Pacific plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 69. Asia Pacific plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 70. Asia Pacific plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 71. Asia Pacific plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 72. Japan plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 73. Japan plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 74. Japan plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 75. Japan plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 76. China plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 77. China plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 78. China plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 79. China plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 80. India plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 81. India plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 82. India plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 83. India plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 84. Australia plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 85. Australia plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 86. Australia plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 87. Australia plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 88. Latin America market size, by country, 2017 - 2021(USD Million)
  • TABLE 89. Latin America market size, by country, 2022 - 2030 (USD Million)
  • TABLE 90. Latin America plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 91. Latin America plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 92. Latin America plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 93. Latin America plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 94. Brazil plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 95. Brazil plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 96. Brazil plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 97. Brazil plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 98. Mexico plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 99. Mexico plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 100. Mexico plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 101. Mexico plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 102. Argentina plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 103. Argentina plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 104. Argentina plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 105. Argentina plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 106. MEA market size, by country, 2017 - 2021(USD Million)
  • TABLE 107. MEA market size, by country, 2022 - 2030 (USD Million)
  • TABLE 108. MEA plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 109. MEA plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 110. MEA plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 111. MEA plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 112. South Africa plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 113. South Africa plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 114. South Africa plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 115. South Africa plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 116. Saudi Arabia plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 117. Saudi Arabia plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 118. Saudi Arabia plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 119. Saudi Arabia plasma derived therapy market, by application, 2022 - 2030 (USD Million)
  • TABLE 120. UAE plasma derived therapy market, by product, 2017 - 2021(USD Million)
  • TABLE 121. UAE plasma derived therapy market, by product, 2022 - 2030 (USD Million)
  • TABLE 122. UAE plasma derived therapy market, by application, 2017 - 2021(USD Million)
  • TABLE 123. UAE plasma derived therapy market, by application, 2022 - 2030 (USD Million)

Charts & Figures

  • FIG.1. Global plasma derived therapy market 360 degree synopsis, 2017 - 2030 (USD Million)
  • FIG.2. Industry segmentation
  • FIG.3. Global plasma derived therapy market, 2017 - 2030 (USD Million)
  • FIG.4. Growth potential analysis, by product
  • FIG.5. Growth potential analysis, by application
  • FIG.6. Porter's analysis
  • FIG.7. PESTEL analysis
  • FIG.8. Key segment trends, by product
  • FIG.9. Key segment trends, by application
  • FIG.10. Key regional trends
  • FIG.11. Competitive dashboard, 2021